Article

pubs.acs.org/joc

Base-Promoted Transannulation of Heterocyclic Enamines and 2,3-
Epoxypropan-1-ones: Regio- and Stereoselective Synthesis of Fused
Pyridines and Pyrroles
Wen-Juan Hao,*,†
†
Zheng Yang,
and Shu-Jiang Tu*,†
†
School of Chemistry and Chemical Engineering, Jiangsu Key Laboratory of Green Synthetic Chemistry for Functional Materials,
Jiangsu Normal University, Xuzhou 221116, P. R. China
‡
Institute of Chemistry & Biomedical Sciences, Nanjing University, Nanjing 210093, P. R. China
§Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409-1061, United States

Bo Jiang,*,†

Guigen Li,

‡,§

Hai-Wei Xu,

Shu-Liang Wang,

†

†

*S Supporting Information

ABSTRACT: Base-promoted transannulation of heterocyclic enam-
ines and 2,3-epoxypropan-1-ones has been successfully achieved,
providing a new access to structurally diverse fused pyridines and
pyrroles with excellent regio- and stereoselectivity. Treatment with N-
aryl 4-aminofuran-2(5H)-ones and 2,3-epoxypropan-1-ones under
microwave heating resulted in functional furo[3,2-b]pyridines in good
yields. The N-aryl 4-aminopyrrol-2(5H)-ones bearing an electron-
withdrawing group engaged in the reaction aﬀorded pyrrolo[3,2-
b]pyridines, whereas their counterparts with an electron-neutral or an
electron-donating group underwent a diﬀerent reaction pathway to
form pyrrolo[3,2-b]pyrroles through C−C bond cleavage.

■ INTRODUCTION

Oxa-aza-containing bicyclic skeletons are omnipresent in a wide
range of naturally and unnaturally occurring products with
important biological activities.1 Among these products, furo-
[3,2-b]pyridine scaﬀolds combining a π-electron rich furan ring
and a π-electron deﬁcient pyridine ring have captured special
interest owing to their synthetic potential. This potential arises
from their substituent diversity as well as their interesting
biological properties. For instance, they can serve as SYK
inhibitors2 (Figure 1,
therapeutic sodium channel
blockers,3 FXa inhibitors,4 nicotinic acetylcholine receptors,5
and retroviral protease inhibitors.6 Furo[3,2-b]pyridine deriv-
atives commonly exist in a wide range of natural alkaloids,

type I),

represented by kopsilactone7 (Figure 1,
type II) and
isofebrifugine8 (type III).
In addition to their biological
beneﬁts,
such heterocycles have proven to be versatile
synthons, and have been eﬃciently employed in the total
synthesis of natural products and the preparation of bioactive
molecules.9 With these attributes in mind,
the scientiﬁc
community devotes a great eﬀort in ﬁnding new synthetic
methods for the synthesis of furo[3,2-b]pyridines and their
structural analogues.

A survey of the literature revealed that substantial synthetic
methods for the formation of functional furo[3,2-b]pyridines
have been developed, which involved carbanionic ring
closure,10 photocyclization of 3-furanyl-3-aminoalkene
imines,11 heteroaromatic C-H insertion of alkylidenecarbenes,12
metal-catalyzed heteroannulation of alkynes,13 and other
methods.14 Nevertheless, most of these approaches suﬀered
from many drawbacks such as a limited substrate scope,
multistep sequences, metal catalysts, and laborious workup.
Therefore, the exploration of new and more eﬃcient synthetic
strategies, especially metal-free pathways, to access function-
alized furo[3,2-b]pyridines is critical to the pharmaceutical and
ﬁne chemical industries.

N-substituted 4-aminofuran-2(5H)-ones possessing C,N-
nucleophilic sites are versatile heterocyclic enamine (aza-ene)

Figure 1. Biologically important furo[3,2-b]pyridine derivatives.

Received:
Published: February 18, 2015

January 9, 2015

© 2015 American Chemical Society

2781

DOI: 10.1021/acs.joc.5b00067
J. Org. Chem. 2015, 80, 2781−2789

The Journal of Organic Chemistry

Article

feedstocks in organic, medicinal, and materials chemistry.15 In
particular, the heterocyclization of N-substituted 4-aminofuran-
2(5H)-ones with a,b-nucleophilic centers has been investigated
extensively over
resulting in well-
developed procedures16 (Figure 2, eq 1). However, in sharp

few decades,

the past

Figure 2. Proﬁling applications of 4-aminofuran-2(5H)-ones.

contrast, the simultaneous functionalization of a,c-active sites on a
4-aminofuran-2(5H)-one ring generating aza-heterocyces has not
been reported so far, although its great potential in C−N bond and
C−C bond formation (eq 2). Due to the inductive eﬀect of the
oxygen atom and the carbonyls on the furan ring, we conceived
that deprotonation at the c-position could provide a suitable
nucleophile, which would enable the construction of important
multifunctional aza-heterocycles. Considering this challenging
project and the great demand for the construction of aza-
heterocycles, we designed a series of furo[3,2-b]pyridines via a
regioselective transannulation between N-aryl 4-aminofuran-
2(5H)-ones and 1,3-diaryl-2,3-epoxypropan-1-ones under
microwave (MW) heating. Using 4-aminopyrrol-2(5H)-ones
2 as replacement for 4-aminofuran-2(5H)-ones 1, this formal (3
+ 3) cycloaddition reaction gave two diﬀerent products
depending on the electronic properties of the substituents on
the aniline moiety of the 4-aminopyrrol-2(5H)-ones. The N-
aryl 4-aminopyrrol-2(5H)-ones 2 bearing an electron-with-
drawing group (EWG) aﬀorded a high yield of the desired
pyrrolo[3,2-b]pyridines, whereas electron-neutral (ENG) and
-donating (EDG) substituents preferred a diﬀerent reaction
pathway,
forming new polyfunctionalized pyrrolo[3,2-b]-
pyrroles through C−C bond cleavage (Scheme 1).
■ RESULTS AND DISCUSSION

To develop metal-free conditions
the regioselective
transannulation, we started our study by preparing N-aryl 4-
aminofuran-2(5H)-ones and 1,3-diaryl-2,3-epoxypropan-1-ones

for

Scheme 1. Synthesis of Substituted Fused Pyridines and
Pyrroles

in our laboratory according to the literature procedure.17 In
order to optimize the reaction conditions, N-4-chlorophenyl 4-
aminofuran-2(5H)-one 1a and 1,3-diphenyl-2,3-epoxypropan-
1-one 3a were investigated as model substrates using diﬀerent
bases for the synthesis of functional furo[3,2-b]pyridines (Table
1).

Table 1. Optimization of Conditions for Forming Product 4a
under MW

entry
1
2
3
4
5
6
7
8
9
10
11

base (equiv)
Et3N (1.0)
EtONa (1.0)
NaOH (1.0)
K2CO3 (1.0)
Cs2CO3 (1.0)
Cs2CO3 (1.0)
Cs2CO3 (1.0)
Cs2CO3 (1.0)
Cs2CO3 (1.0)
Cs2CO3 (1.0)
Cs2CO3 (1.0)

aIsolated yield.

solvent

temp (°C)

yielda /%

ethylene glycol
ethylene glycol
ethylene glycol
ethylene glycol
ethylene glycol
EtOH
CH3CN
DMF
ethylene glycol
ethylene glycol
ethylene glycol

100
100
100
100
100
100
100
100
80
120
130

trace
trace
31
52
74
69
32
12
70
81
79
<para sub=“opt”>
As shown in Table 1, the reaction aﬀorded only trace product
in the presence of Et3N and EtONa (1.0 equiv) in ethylene
glycol (EG) at 100 °C for 15 min. The desired product 4a was
isolated in poor yield (31%) using NaOH as a base promoter.
The use of K2CO3 gave higher yield (up to 52%). To our
delight, the desired product 4a was obtained in 74% yield in the
presence of Cs2CO3 (1.0 equiv) (Table 1, entry 5). Taking
Cs2CO3 as the optimized base, we varied other parameters.
Other polar solvents such as EtOH, acetonitrile, and DMF were
inferior to ethylene glycol in terms of reaction yields. Next, the
reaction temperature was investigated. Raising the temperature
slightly to 120 °C proved more eﬃcient, aﬀording the expected
product 4a in 81% yield. Further lowering or raising of the
reaction temperature did not signiﬁcantly change the yield
(entries 9 and 11).
</para>
<para sub="scope">
The scope for N-aryl enamines was investigated ﬁrst under
the optimized conditions [Cs2CO3 (1.0 equiv), EG, 120 °C,
MW] (Scheme 2). First, the eﬀects of N-substituents on 4-
aminofuran-2(5H)-ones were investigated by employing diﬀer-
ent aryl groups bearing a variety of electron-withdrawing
(chloro and bromo) or electron-donating groups (such as
methyl and methoxyl). Among them, N-substituents bearing
withdrawing groups showed the higher reactivity than their
electron-donating counterparts. For
instance, 4-((4-bromo-
phenyl)amino)furan-2(5H)-one 1b with a bromo group
reacted with 1,3-diphenyl-2,3-epoxypropan-1-ones 3a, aﬀording
the corresponding product 4b in 82% yield. The presence of a
methyl group on the phenyl ring of substrate 1f resulted in the
desired product 4f in 66% yield. The exact structure of product
4j was unequivocally determined by single-crystal X-ray
analysis. These experimental facts indicated that the electronic
nature of the N-substituents seemed to exert a delicate eﬀect on
the reactivity. Then, a series of 1,3-diaryl-2,3-epoxypropan-1-
ones with electronically poor substituents linked to the Ar2 ring
</para>
2782

DOI: 10.1021/acs.joc.5b00067
J. Org. Chem. 2015, 80, 2781−2789

The Journal of Organic Chemistry
Scheme 2. Synthesis of Functional Furo[3,2-b]pyridinesa,b

Article

bases and solvents for the optimized conditions (Table 2). The
use of 1.0 equiv of Cs2CO3, NaOH, and Et3N as well as EtONa

Table 2. Optimization of Conditions for Forming Product 5a

entry
1
2
3
4
5
6
7
8
9
10
11
12

base (equiv)
Cs2CO3 (1.0)
Cs2CO3 (1.0)
Cs2CO3 (1.0)
Et3N (1.0)
NaOH (1.0)
EtONa (1.0)
t-BuOK (1.0)
t-BuOLi (1.0)
t-BuOLi (1.0)
t-BuOLi (1.0)
t-BuOLi (1.0)
t-BuOLi (1.0)

solvent

temp (°C)

yield (%)

ethylene glycol
ethylene glycol
DMF
DMF
DMF
DMF
DMF
DMF
CH3CN
EtOH
DMF
DMF

120
50
50
50
50
50
50
50
50
50
60
40

no
no
trace
trace
trace
12
52
61
60
41
82
50
<para sub=“opt”>
in DMF was met with little success (Table 2, entries 2−6).
Stronger bases such as t-BuOK and t-BuOLi were then tried,
and 1.0 equiv of t-BuOK gave the target product 5a in 52%
yield (entry 7). Exchanging t-BuOK for t-BuOLi (1.0 equiv) led
to a slightly higher yield (61% yield, entry 8). After careful
optimizations, we found that t-BuOLi (1.0 equiv) in DMF at 60
°C was the most suitable condition for the cycloaddition
reaction, aﬀording the expected product in the best yield of
82% (entry 11).
</para>
<para sub="scope">
this protocol

With the established optimal conditions, we were eager to
investigate the substrate scope of 4-aminopyrrol-2(5H)-one 2a
and 1,3-diaryl-2,3-epoxypropan-1-ones 3. As shown in Scheme
tolerates a broad range of 1,3-diaryl-2,3-
3,
epoxypropan-1-ones,
leading to a highly diastereoselective
synthesis of structurally diverse pyrrolo[3,2-b]pyridines in
generally good yields. In detail, 1,3-diaryl-2,3-epoxypropan-1-
ones 3 carrying either electronically poor, neutral, or rich
groups could successfully participate in the [3 + 3] cyclo-
addition with 4-aminopyrrol-2(5H)-one 2 with electron-
withdrawing substituents in overall acceptable yields (up to
82%) and high stereoselectivity (only one isomer except 5c).
However, the bulk steric hindrance related to 1,3-diaryl-2,3-
epoxypropan-1-ones decreased this reactive behavior, leading to
relatively lower yields for products 5e−5g. Furthermore, 4-
aminopyrrol-2(5H)-ones 2 bearing electron-neutral or electron-
rich groups were examined by the reactions with 1,3-diaryl-2,3-
epoxypropan-1-ones 3 under
the optimal conditions. Un-
the target pyrrolo[3,2-b]pyridines 5 were not
expectedly,
obtained. Instead, the reaction underwent another direction
to form new polyfunctionalized pyrrolo[3,2-b]pyrroles 6
through C−C bond cleavage (Scheme 4). Next, we set out to
vary the substituents of 4-aminopyrrol-2(5H)-ones 2 and
treated these derivatives to the treatment with 1,3-diphenyl-2,3-
epoxypropan-1-one 3a. Both methyl and methoxy functional
groups
in the 4-aminopyrrol-2(5H)-ones delivered the
corresponding pyrrolo[3,2-b]pyrroles 6b−c with good yields
(Scheme 4, eq 1). Finally, single-crystal X-ray diﬀraction
analysis of 6b was carried out
structural
further
conﬁrmation. This above observation illustrates
that
the
</para>
for

2783

DOI: 10.1021/acs.joc.5b00067
J. Org. Chem. 2015, 80, 2781−2789

aReaction conditions: 1 (1.0 mmol), 3 (1.0 mmol), Cs2CO3 (1.0
mmol), ethylene glycol (1.5 mL), 120 °C, MW. bIsolated yield based
on substrate 1.
<para sub="scope">
were utilized in the transannulation, generating the desired
furo[3,2-b]pyridines containing two stereogenic centers in
generally high yields and excellent diastereoselectivity (only one
isomer except 4n−4p). Among them, bulky 2-subsituted Ar2
groups lowered the yield of the cycloaddition reaction relative
to those obtained with 2-unsubsituted analogues, which
indicated that the steric hindrance exerted some inﬂuence on
the reactivity of the substrates. These examples showed the
eﬃciency and applicability of this strategy to the simultaneous
functionalization of the a,c-active sites on the 4-aminofuran-
2(5H)-one ring.
</para>
<para sub=“opt”>
After our success with functional furo[3,2-b]pyridines 4, we
turned our attention to evaluating the feasibility of the synthesis
of pyrrolo[3,2-b]pyridines 5. The cycloaddition reaction
between N-4-chlorophenyl 4-aminopyrrol-2(5H)-one 2a and
1,3-diphenyl-2,3-epoxypropan-1-one 3a was conducted under
the conditions described above. The expected pyrrolo[3,2-
b]pyridines 5a could not be obtained.
Instead, a black
gelatinous
likely due to the
decomposition of 4-aminopyrrol-2(5H)-one 2a as a result of
the high temperature. Lowering the reaction temperature from
120 to 50 °C failed to give the product 5a. Next, we adjusted
liquid was observed, most
</para>
The Journal of Organic Chemistry
Scheme 3. Synthesis of Functional Pyrrolo-Fused Pyridines 5a,b

Article

aReaction conditions: 2 (1.0 mmol), 3 (1.0 mmol), t-BuOLi (1.0 mmol), DMF (1.5 mL), 60 °C, MW. bIsolated yield based on substrate 2.

Scheme 4. Synthesis of Functional Pyrrolo-Fused Pyrroles
6a,b
<para sub="scope">
decorated fused pyrrol-2(5H)-ones, which are ubiquitous
in a substantial number of bioactive
structural units
compounds.
</para>
<para sub="scope">
After the formation of functional products 4−6, we devoted
the new
our eﬀorts to further probe the generality of
Instead of heterocyclic enamines 1 or 2,
transannulation.
carbocyclic or acyclic enamines 7a−c were employed to react
with substrate 3a, respectively (Scheme 5). Unfortunately,
</para>
Scheme 5. Exploration of Reaction Scope

aReaction conditions: 2 (1.0 mmol), 3 (1.0 mmol), t-BuOLi (1.0
mmol), DMF (1.5 mL), 60 °C, MW. bIsolated yield based on
substrate 2.
<para sub="scope">
electronic nature of the substituents on the 4-aminopyrrol-
2(5H)-ones may control chemoselectivity of the reaction. In
order to gain insight regarding the C−C bond cleavage, some
control experiments were performed under the optimal reaction
conditions using diﬀerent substituents linked to the benzene
ring of 1,3-diaryl-2,3-epoxypropan-1-one 3. (4-Chlorophenyl)-
(3-phenyloxiran-2-yl)methanone and (3-(4-bromophenyl)-
oxiran-2-yl)(4-methoxyphenyl)methanone were reacted with
4-(p-tolylamino)-1H-pyrrol-2(5H)-one, respectively, transform-
ing readily into 4-chlorophenyl and 4-methoxyphenyl sub-
stituted pyrrolo[3,2-b]pyrroles 6d (62%) and 6e (72%)
(Scheme 4, eqs 2 and 3). This suggested that the C−C bond
cleavage occurred in the oxirane ring. In general, this new
transannulation gives new examples for the formation of richly
</para>
<para sub="scope">
almost all of the starting material was recovered and the desired
product 8 was not detected at all. It is obvious that these
carbocyclic or acyclic enamines 7a−c showed poor reactivity in
the cycloaddition reaction.
</para>
<para sub="scope">
On the basis of our experimental observations and literature
precedents, plausible mechanistic pathways to products 4−6 are
illustrated in Schemes 6 and 7. Initially, nucleophilic addition of
heterocyclic enamines 1 or 2 (Ar1 = EWG) to the β-position of
oxiranes 3 in the presence of base generates intermediate A,
followed by H-transfer and intramolecular Knoevenagel
fused pyridines 4 and 5
condensation,
(Scheme 6). Heterocyclic enamines 2 carrying electron-
donating (EDG) and electron-neutral (ENG) aryl rings may
enhance C5 nucleophilicity of
the pyrrol-2(5H)-one ring,
thereby favoring aldol-type reaction of oxiranes 3. In view of
this consideration, the N-position of heterocyclic enamines 2c−
e (Ar1 = EDG or ENG) is activated by strong base, which
undergoes 1,3-H transfer to form intermediate C. Intermediate
C facilitates aldol-type reaction of oxiranes 3, providing adduct
intermediate D. Next, the N-position of adduct intermediate D

to aﬀord the ﬁnal
</para>
2784

DOI: 10.1021/acs.joc.5b00067
J. Org. Chem. 2015, 80, 2781−2789

The Journal of Organic Chemistry
Scheme 6. Plausible Mechanistic Pathways to Products 4−5

Scheme 7. Plausible Mechanistic Pathways to Products 6
<para sub="scope">
attacks selectively on the α-position of oxiranes 3 in an
intramolecular manner, giving rise to intermediate E.
Intermediate E releases an aryl aldehyde and a hydroxyl
anion to yield pyrrolo[3,2-b]pyrrole intermediate F, which
converted into the ﬁnal pyrrolo[3,2-b]pyrroles 6 through
tautomerization (Scheme 7). In both reactions, the key steps
of bifurcate transannulations to diﬀerent products involve
nucleophilic addition of heterocyclic enamines to diﬀerent
positions of oxiranes 3, despite that the detailed reason for
these divergent additions is not yet clear to us.
</para>
In summary, we have established a new and versatile base-
promoted transannulation of heterocyclic enamines and 2,3-
epoxypropan-1-ones, allowing the conversion of simple starting
materials into substituted fused pyridines and pyrroles with
excellent regio- and stereoselectivity. The formal [3 + 3]
cycloaddition simultaneously installs a C−N and a C−C bond
through a key C−O bond cleavage process, enabling the
eﬃcient synthesis of diverse furo[3,2-b]pyridines and pyrrolo-
[3,2-b]pyridines with biological relevance. The latter provides a
new insight into the [3 + 2] heterocyclization, depending on
the electronic properties of the substituents on the aniline
moiety of the 4-aminopyrrol-2(5H)-ones, which represents a
special example for forming pyrrolo[3,2-b]pyrroles through a
C−O bond and a C−C bond cleavage process. Further study of
the mechanism of
transformations and
evaluation of their biological activity are in progress.

these divergent

■ EXPERIMENTAL SECTION
<para sub=“exp”>
General. Microwave irradiation was carried out with Initiator 2.5
Microwave Synthesizers from Biotage, Uppsala, Sweden. The reaction
temperatures were measured by an infrared detector during microwave
heating.
</para>
Article
<para sub=“exp”>
General Procedure for the Synthesis of 4. Example for the
Synthesis of 4a. 4-((4-Chlorophenyl)amino)furan-2(5H)-one (1a, 1.0
mmol, 209 mg) was introduced in a 10 mL Initiator reaction vial; 1,3-
diphenyl-2,3-epoxypropan-1-ones (3a, 1.0 mmol, 224 mg) and
Cs2CO3 (1.0 mmol, 326 mg) as well as ethylene glycol (1.5 mL)
were then successively added. Subsequently, the reaction vial was
capped and then prestirred for 20 s. The mixture was irradiated (time,
20 min; temperature, 120 °C; absorption level, high; ﬁxed hold time)
until TLC (petroleum ether/acetone V/V = 3/1) revealed that
conversion of the starting material 1a was complete. The system was
diluted with cold water (40 mL). The solid product was collected by
Büchner ﬁltration and puriﬁed by ﬂash column chromatography (silica
gel, mixtures of petroleum ether/ethyl acetate) to aﬀord the pure
product 4a.

4-(4-Chlorophenyl)-6-hydroxy-5,7-diphenyl-5,6-dihydrofuro[3,2-
b]pyridin-2(4H)-one (4a). Yellow solid (336 mg, 81% yield): mp
201−203 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.73 (d, J = 8.0 Hz, 2H), 7.50 (d,
J = 8.8 Hz, 2H), 7.42 (t, J = 7.6 Hz, 2H), 7.38−7.33 (m, 7H), 7.28 (s,
1H), 6.39 (d, J = 7.6 Hz, 1H), 5.38 (s, 1H), 5.22 (s, 1H), 4.84 (d, J =
7.6 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 169.9, 154.8, 142.3,
142.2, 137.8, 133.8, 130.6, 130.1, 129.5, 129.1, 128.6, 128.4, 126.5,
124.9, 112.4, 82.3, 71.4, 70.3; IR (KBr, v) 3351, 2341, 1737, 1606,
1494, 1216, 1011, 847, 695 cm−1; HRMS (APCI-TOF) m/z calcd for
[M + H]+ C25H19ClNO3 416.1053, found 416.1068.

4-(4-Bromophenyl)-6-hydroxy-5,7-diphenyl-5,6-dihydrofuro[3,2-
b]pyridin-2(4H)-one (4b). Yellow solid (375 mg, 82% yield): mp
212−214 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.72 (d, J = 7.6 Hz, 2H), 7.62 (d,
J = 8.8 Hz, 2H), 7.42 (t, J = 7.6 Hz, 2H), 7.37−7.33 (m, 5H), 7.27 (d,
J = 8.8 Hz, 3H), 6.37 (d, J = 7.6 Hz, 1H), 5.39 (s, 1H), 5.22 (s, 1H),
4.84 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 169.9,
154.6, 142.7, 142.2, 137.8, 133.8, 133.0, 129.5, 129.1, 128.6, 128.4,
126.5, 125.2, 118.8, 112.5, 82.4, 71.4, 70.3; IR (KBr, v) 3381, 2341,
1741, 1615, 1488, 1251, 1072, 872, 698 cm−1; HRMS (APCI-TOF)
m/z calcd for [M + H]+ C25H19BrNO3 462.0526, found 462.0520.

4-(3,4-Dichlorophenyl)-6-hydroxy-5,7-diphenyl-5,6-dihydrofuro-
[3,2-b]pyridin-2(4H)-one (4c). White solid (314 mg, 70% yield): mp
223−225 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.71 (m, 3H), 7.53 (d, J = 2.8
Hz, 1H), 7.44−7.29 (m, 9H), 6.39 (d, J = 7.6 Hz, 1H), 5.50 (s, 1H,),
5.29 (s, 1H), 4.85 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, DMSO-
d6) δ 169.8, 154.4, 143.4, 142.0, 137.6, 133.8, 132.4, 132.0, 129.6,
129.2, 129.1, 128.7, 128.6, 128.5, 126.5, 125.0, 123.4, 112.8, 83.4, 71.3,
70.1; IR(KBr, v) 3358, 2361, 1737, 1603, 1475, 1288, 1037, 895, 695
cm−1; HRMS (APCI-TOF) m/z calcd for [M + H]+ C25H18Cl2NO3
450.0658, found 450.0654.

4-(3,5-Dichlorophenyl)-6-hydroxy-5,7-diphenyl-5,6-dihydrofuro-
[3,2-b]pyridin-2(4H)-one (4d). Pale white solid (265 mg, 59% yield):
mp 237−239 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.72 (d, J = 7.2 Hz, 2H), 7.52 (s,
1H), 7.45−7.39 (m, 3H), 7.37 (d, J = 2.0 Hz, 3H), 7.32 (d, J = 1.6 Hz,
4H), 6.34 (d, J = 8.0 Hz, 1H,), 5.57 (s, 1H), 5.32 (s, 1H), 4.86 (d, J =
8.0 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 169.7, 154.2, 145.7,
142.0, 137.5, 135.3, 133.7, 129.6 129.2, 129.1, 128.7, 128.5, 126.5,
126.2, 121.9, 112.9, 84.1, 71.3, 70.0; IR (KBr, v) 3391, 2361, 1730,
1572, 1447, 1212, 1044, 811, 852, 692 cm−1; HRMS (APCI-TOF) m/
z calcd for [M + H]+ C25H18Cl2NO3 450.0658, found 450.0657.
one (4e). Pale white solid (271 mg, 71% yield): mp 243−245 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.73 (d, J = 7.6 Hz, 2H), 7.43 (d,
J = 7.6 Hz, 4H), 7.37−7.32 (m, 7.0 Hz, 7H), 7.27 (d, J = 7.2 Hz, 2H),
6.36 (d, J = 7.6 Hz, 1H), 5.28 (s, 1H), 5.23 (s, 1H), 4.83 (d, J = 7.2
Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 170.0, 155.0, 143.4,
142.3, 138.1, 133.9, 130.1, 129.5, 129.1, 129.0, 128.6, 128.3, 126.7,
126.6, 123.1, 112.2, 81.5, 71.5, 70.4; IR (KBr, v) 3369, 2342, 1738,
1614, 1493, 1274, 1048, 869, 695 cm−1; HRMS (APCI-TOF) m/z
calcd for [M + H]+ C25H20NO3 382.1438, found 382.1439.

6-Hydroxy-4,5,7-triphenyl-5,6-dihydrofuro[3,2-b]pyridin-2(4H)-
</para>
2785

DOI: 10.1021/acs.joc.5b00067
J. Org. Chem. 2015, 80, 2781−2789

The Journal of Organic Chemistry

Article
<para sub=“exp”>
6-Hydroxy-5,7-diphenyl-4-(p-tolyl)-5,6-dihydrofuro[3,2-b]pyridin-
2(4H)-one (4f). Pale white solid (261 mg, 66% yield): mp 246−248
°C.
1H NMR (400 MHz, DMSO-d6) δ 7.72 (d, J = 7.6 Hz, 2H), 7.41 (t,
J = 7.6 Hz, 2H), 7.38−7.30 (m, 5H), 7.29−7.20 (m, 5H), 6.35 (d, J =
7.2 Hz, 1H), 5.18 (s, 2H), 4.80 (d, J = 7.6 Hz, 1H), 2.29 (s, 3H); 13C
NMR (100 MHz, DMSO-d6) δ 170.0, 155.2, 142.3, 140.9, 138.1,
136.3, 134.0, 130.6, 129.4, 129.1, 129.0, 128.6, 128.3, 126.6, 123.4,
112.1, 80.9, 71.4, 70.6, 21.0; IR (KBr, v) 3691, 2361, 1742, 1599,
1509,1436, 1034, 867, 699 cm−1; HRMS (APCI-TOF) m/z calcd for
[M + H]+ C26H22NO3 396.1564, found 396.1564.

6-Hydroxy-4-(4-methoxyphenyl)-5,7-diphenyl-5,6-dihydrofuro-
[3,2-b]pyridin-2(4H)-one (4g). White solid (255 mg, 63% yield): mp
239−241 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.72 (d, J = 7.6 Hz, 2H), 7.41 (t,
J = 7.6 Hz, 2H), 7.36−7.31 (m, 5H), 7.26 (d, J = 9.2 Hz, 3H), 6.99 (d,
J = 9.2 Hz, 2H), 6.35 (d, J = 7.6 Hz, 1H), 5.12 (s, 1H), 5.04 (s, 1H),
4.78 (d, J = 7.2 Hz, 1H), 3.74 (s, 3H); 13C NMR (100 MHz, DMSO-
d6) δ 170.0, 158.0, 155.7, 142.2, 138.0, 136.1, 134.0, 129.4, 129.1,
129.0, 128.6, 128.3, 126.7, 125.4, 115.3, 112.0, 80.2, 71.5, 71.0, 55.8; IR
(KBr, v) 3375, 2342, 1740, 1599, 1510, 1247, 1032, 865, 759, 669
cm−1; HRMS (APCI-TOF) m/z calcd for [M + H]+ C26H22NO4
412.1543, found 412.1543.

4-(3-Bromo-4-methylphenyl)-6-hydroxy-5,7-diphenyl-5,6-
dihydrofuro[3,2-b]pyridin-2(4H)-one (4h). White solid (359 mg, 76%
yield): mp 240−242 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.72 (d, J = 7.6 Hz, 2H), 7.50 (d,
J = 2.0 Hz, 1H), 7.44−7.39 (m, 3H), 7.38−7.32 (m, 5H), 7.30−7.25
(m, 2H), 6.34 (d, J = 7.6 Hz, 1H), 5.29 (s, 1H), 5.22 (s, 1H), 4.82 (d, J
= 7.6 Hz, 1H), 2.33 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 169.8,
154.9, 142.4, 142.1, 137.7, 136.0, 133.9, 132.3, 129.5, 129.1, 128.6,
128.4, 126.8, 126.6, 124.8, 122.8, 112.5, 82.0, 71.4, 70.4, 22.4; IR (KBr,
v) 3374, 2342, 1742, 1590, 1494, 1212, 1039, 775, 693 cm−1; HRMS
(APCI-TOF) m/z calcd for [M + H]+ C26H21BrNO3 476.0683, found
476.0687.

4,5-Bis(4-chlorophenyl)-6-hydroxy-7-phenyl-5,6-dihydrofuro[3,2-
b]pyridin-2(4H)-one (4i). Pale white solid (305 mg, 68% yield): mp
209−211 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.73 (d, J = 7.2 Hz, 2H), 7.50 (d,
J = 8.8 Hz, 2H), 7.42 (t, J = 6.4 Hz, 4H), 7.38−7.31 (m, 5H), 6.41 (s,
1H), 5.38 (s, 1H), 5.24 (s, 1H), 4.81 (s, 1H); 13C NMR (100 MHz,
DMSO-d6) δ 169.8, 154.6, 142.1, 136.8, 133.7, 133.1, 130.7, 130.2,
129.5, 129.1, 128.6, 128.6, 125.0, 112.4, 82.6, 71.1, 69.6; IR (KBr, v)
3379, 2341, 1736, 1585, 1492, 1255, 1092, 781, 688 cm−1; HRMS
(APCI-TOF) m/z calcd for [M + H]+ C25H18Cl2NO3 450.0663, found
450.0660.

4-(4-Bromophenyl)-5-(4-chlorophenyl)-6-hydroxy-7-phenyl-5,6-
dihydrofuro[3,2-b]pyridin-2(4H)-one (4j). Yellow solid (330 mg, 67%
yield): mp 200−202 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.72 (d, J = 8.0 Hz, 2H), 7.50 (d,
J = 8.8 Hz, 2H), 7.45−7.41 (m, 4H), 7.39−7.32 (m, 3H), 7.26 (d, J =
8.8 Hz, 2H), 6.39 (d, J = 7.6 Hz, 1H), 5.39 (s, 1H), 5.24 (s, 1H), 4.82
(d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 169.9, 154.5,
142.7, 142.2, 137. 3, 133.8, 133.2, 132.5, 132.0, 129.2, 129.0, 128.7,
125.3, 121.8, 119.0, 112.5, 82.8, 71.2, 69.7; IR (KBr, v) 3348, 2330,
1721, 1618, 1490, 1210, 1011, 854, 702 cm−1; HRMS (APCI-TOF)
m/z calcd for [M + H]+ C25H18BrClNO3 496.0133, found 496.0132.
5-(4-Chlorophenyl)-4-(3,4-dichlorophenyl)-6-hydroxy-7-phenyl-
5,6-dihydrofuro[3,2-b]pyridin-2(4H)-one (4k). Pale yellow solid (280
mg, 58% yield): mp 219−221 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.74−7.68 (m, 3H), 7.55 (s,
1H), 7.44−7.41 (m, 4H), 7.37 (d, J = 8.8 Hz, 3H), 7.29 (d, J = 8.8 Hz,
1H), 6.37 (d, J = 8.0 Hz, 1H), 5.50 (s, 1H), 5.30 (s, 1H), 4.83 (d, J =
8.0 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 169.7, 154.2, 143.2,
142.0, 136.6, 133.7, 133.1, 132.4, 132.0, 129.5, 129.2, 129.1, 128.8, 128.
7, 128.6, 125.2, 123.5, 112.8, 83.7, 71.1, 69.4; IR (KBr, v) 3387, 2361,
1733, 1604, 1415, 1287, 1117, 783, 691 cm−1; HRMS (APCI-TOF)
m/z calcd for [M + H]+ C25H17Cl3NO3 486.0243, found 486.0243.

4,5-Bis(4-bromophenyl)-6-hydroxy-7-phenyl-5,6-dihydrofuro[3,2-
b]pyridin-2(4H)-one (4l). White yellow solid (372 mg, 65% yield): mp
222−224 °C.

1H NMR (400 MHz, DMSO-d6) δ 7.73 (d, J = 7.6 Hz, 2H), 7.63 (d,
J = 8.8 Hz, 2H), 7.56 (d, J = 8.4 Hz, 2H), 7.43 (t, J = 7.6 Hz, 2H),
7.37−7.24 (m, 5H), 6.41 (d, J = 7.6 Hz, 1H), 5.40 (s, 1H), 5.23 (s,
1H), 4.82 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ
169.8, 154.4, 142.5, 142.1, 137.2, 133.7, 133.1, 132.4, 129.1, 128.9,
128.6, 125.2, 121.7, 118.9, 112.4, 82.7, 71.1, 69.6; IR (KBr, v) 3364,
1719, 1624, 1433, 1307, 1261, 1011, 837, 720, 691 cm−1; HRMS
(APCI-TOF) m/z calcd for [M + H]+ C25H18Br2NO3 539.9633, found
539.9629.

5-(2,3-Dichlorophenyl)-4-(4-ﬂuorophenyl)-6-hydroxy-7-phenyl-
5,6-dihydrofuro[3,2-b]pyridin-2(4H)-one (4m). Pale white solid (262
mg, 56% yield): mp 213-215 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.72−7.62 (m, 3H), 7.43−7.36
(m, 9H), 6.76 (s, 1H), 5.43 (s, 1H), 5.23 (s, 1H), 4.76 (s, 1H); 13C
NMR (100 MHz, DMSO-d6) δ 169.7, 160.0 (1JCF = 243.4 Hz), 155.3,
142.0, 139.3, 137.0, 133.7, 133.3, 131.0, 130.2 (3JCF = 7.1 Hz), 129.5
129.2, 128.6, 126.5, 126.2, 126.1, 117.3 (2JCF = 22.9 Hz), 112.2, 82.2,
68.9, 68.9; IR(KBr, v) 3385, 2341, 1732, 1606, 1413, 1218, 1055, 864,
692 cm−1; HRMS (APCI-TOF) m/z calcd for [M + H]+
C25H17Cl2FNO3 468.0564, found 468.0556.

4-(4-Bromophenyl)-5-(2,3-dichlorophenyl)-6-hydroxy-7-phenyl-
5,6-dihydrofuro[3,2-b]pyridin-2(4H)-one (4n). White solid (332 mg,
63% yield): mp 239−241 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.71 (d, J = 7.6 Hz, 2H), 7.65 (d,
J = 8.8 Hz, 3H), 7.61 (s, 1H), 7.46−7.40 (m, 3H), 7.40−7.34 (m, 2H),
7.26 (d, J = 8.8 Hz, 2H), 6.75 (d, J = 7.6 Hz, 1H), 5.44 (s, 1H), 5.38
(s, 1H), 4.77 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ
169.7, 154.6, 142.3, 142.0, 136.9, 133.7, 133.3, 132.7, 131.0, 130.1,
129.5, 129.2, 128.6, 126.4, 125.5, 123.2, 119.5, 112.3, 83.2, 68.8, 68.6;
IR (KBr, v) 3376, 2360, 1734, 1602, 1414, 1286, 1052, 896, 692 cm−1;
HRMS (APCI-TOF) m/z calcd for [M + H]+ C25H17BrCl2NO3
529.9742, found 529.9736.

4,5-Bis(2,3-dichlorophenyl)-6-hydroxy-7-phenyl-5,6-dihydrofuro-
[3,2-b]pyridin-2(4H)-one (4o). White solid (315 mg, 61% yield): mp
236−238 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.71 (d, J = 8.0 Hz, 3H), 7.65−
7.61 (m, 2H), 7.42 (d, J = 8.0 Hz, 3H), 7.37−7.32 (m, 2H), 7.25 (d, J
= 6.4 Hz, 1H), 6.71 (d, J = 7.6 Hz, 1H), 5.49 (s, 1H), 5.46 (s, 1H),
4.79 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 169.6,
154.4, 142.9, 141.8, 136.6, 133.6, 133.3, 132.6, 132.4, 131.1, 130.2,
129.6, 129.5, 129.3, 129.2, 128.9, 128.6, 125.8, 121.0, 112.5, 84.0, 68.9,
68.6; IR (KBr, v) 3350, 2338, 1732, 1574, 1475, 1283,1096, 864, 688
cm−1; HRMS (APCI-TOF) m/z calcd for [M + H]+ C25H16Cl4NO3
519.9852, found 519.9851.

5-(2,3-Dichlorophenyl)-4-(3,5-dichlorophenyl)-6-hydroxy-7-phe-
nyl-5,6-dihydrofuro[3,2-b]pyridin-2(4H)-one (4p). Yellow solid (300
mg, 58% yield): mp 232−234 °C.

1H NMR (400 MHz, DMSO-d6) δ 7.71 (d, J = 7.3 Hz, 2H), 7.63 (d,
J = 6.4 Hz, 1H), 7.58 (s, 1H), 7.42 (d, J = 8.0 Hz, 3H), 7.36 (d, J = 2.0
Hz, 4H), 6.69 (d, J = 7.6 Hz, 1H), 5.52 (s, 1H), 5.49 (s, 1H), 4.81 (d, J
= 7.6 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 169.5, 154.2, 145.2,
141.7, 136.5, 135.6, 133.5, 133.3, 131.1, 130.1, 129.6, 129.3, 129.2,
128., 127.1, 126.5, 122.7, 112.7, 84.6, 68.8, 68.5; IR (KBr, v) 3424,
2361, 1735, 1605, 1409, 1297,1117, 874, 689 cm−1; HRMS (APCI-
TOF) m/z calcd for [M + H]+ C25H16Cl4NO3 519.9852,
found
519.9854.

5-(2,4-Dichlorophenyl)-4-(3,4-dichlorophenyl)-6-hydroxy-7-phe-
nyl-5,6-dihydrofuro[3,2-b]pyridin-2(4H)-one (4q). White solid (331
mg, 64% yield): mp 228−230 °C.

1H NMR (400 MHz, DMSO-d6) δ 7.71 (d, J = 9.2 Hz, 4H), 7.61 (s,
1H), 7.44 (t, J = 7.6 Hz, 3H), 7.36 (t, J = 7.6 Hz, 2H), 7.26 (d, J = 8.8
Hz, 1H), 6.72 (d, J = 7.6 Hz, 1H), 5.50 (s, 1H), 5.39 (s, 1H), 4.76 (d, J
= 7.6 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 169.6, 154.4, 142.9,
141.8, 134.3, 133.6, 133.2, 133.2, 132.6, 132.4, 130.5, 129.6, 129.3,
129.2, 129.2, 128.8, 128.6, 125.8, 123.8, 112.5, 84.0, 68.9, 67.6; IR
(KBr, v) 3352, 1776, 1467, 1333, 1048, 836, 700, 654 cm−1; HRMS
</para>
2786

DOI: 10.1021/acs.joc.5b00067
J. Org. Chem. 2015, 80, 2781−2789

The Journal of Organic Chemistry

Article
<para sub=“exp”>
(APCI-TOF) m/z calcd for [M + H]+ C25H16Cl4NO3 519.9852, found
519.9861.

5-(2,4-Dichlorophenyl)-4-(3,5-dichlorophenyl)-6-hydroxy-7-phe-
nyl-5,6-dihydrofuro[3,2-b]pyridin-2(4H)-one (4r). Pale white solid
(321 mg, 62% yield): mp 224−226 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.75−7.67 (m, 3H), 7.59 (s,
1H), 7.44 (t, J = 7.6 Hz, 3H), 7.36 (d, J = 8.4 Hz, 4H), 6.69 (d, J = 7.6
Hz, 1H), 5.55 (s, 1H), 5.41 (s, 1H), 4.77 (d, J = 7.6 Hz, 1H); 13C
NMR (100 MHz, DMSO-d6) δ 169.5, 154.2, 145.2, 141.8, 135.6,
134.4, 133.5, 133.1, 133.0, 130.5, 129.3, 129.2, 128.9, 128.6, 127.1,
122.6, 112.6, 84.7, 68.9, 67.6; IR (KBr, v) 3371, 2259, 1737, 1679,
1468, 1297, 1097, 854, 694 cm−1; HRMS (APCI-TOF) m/z calcd for
[M + H]+ C25H16Cl4NO3 519.9852, found 519.9844.

5-(2,4-Dichlorophenyl)-6-hydroxy-7-phenyl-4-(p-tolyl)-5,6-
dihydrofuro[3,2-b]pyridin-2(4H)-one (4s). White solid (324 mg, 70%
yield): mp 220−222 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.73−7.69 (m, 3H), 7.47−7.42
(m, 3H), 7.37−7.33 (m, 2H), 7.27 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4
Hz, 2H), 6.72 (d, J = 7.6 Hz, 1H), 5.38 (s, 1H), 5.18 (s, 1H), 4.71 (d, J
= 7.6 Hz, 1H), 2.29 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 169.8,
155.2, 142.1, 140.4, 137.0, 134.1, 133.8, 133.7, 133.2, 130.8, 130.4,
129.2, 128.7, 128.6, 123.7, 112.0, 81.7, 69.0, 67.8, 21.0; IR (KBr, v)
3308, 2342, 1735, 1654, 1431, 1271, 1039, 883, 682 cm−1; HRMS
(APCI-TOF) m/z calcd for [M + H]+ C26H20Cl2NO3 464.0815, found
464.0819.

5-(2,4-Dichlorophenyl)-6-hydroxy-4-(4-methoxyphenyl)-7-phe-
nyl-5,6-dihydrofuro[3,2-b]pyridin-2(4H)-one (4t). Yellow solid (311
mg, 65% yield): mp 236−239 °C.
1H NMR (400 MHz, DMSO-d6) δ 7.72 (d, J = 7.6 Hz, 2H), 7.69 (s,
1H), 7.48−7.42 (m, 3H), 7.40−7.34 (m, 2H), 7.27 (d, J = 8.8 Hz,
2H), 7.01 (d, J = 8.8 Hz, 2H), 6.72 (d, J = 7.6 Hz, 1H), 5.35 (s, 1H),
5.06 (s, 1H), 4.70 (d, J = 7.6 Hz, 1H), 3.75 (s, 3H); 13C NMR (100
MHz, DMSO-d6) δ 169.8, 158.3, 155.7, 142.0, 135.6, 134.1, 133.8,
133.6, 133.3, 130.3, 129.2, 129.2, 129.1, 128.7, 128.5, 125.7, 115.5,
111.9, 81.1, 69.0, 68.1, 55.8; IR (KBr, v) 3396, 2341, 1727, 1595, 1425,
1219, 1042, 879, 696 cm−1; HRMS (APCI-TOF) m/z calcd for [M +
H]+ C26H20Cl2NO4 480.0764, found 480.0733.

General Procedure for the Synthesis of 5. Example for the
Synthesis of 5a. 4-((4-Chlorophenyl)amino)-1H-pyrrol-2(5H)-one
(2a, 1.0 mmol, 208 mg) was introduced in a 10 mL Initiator reaction
vial; 1,3-diphenyl-2,3-epoxypropan-1-one (3a, 1.0 mmol, 224 mg) and
t-BuOLi (1.0 mmol, 80 mg) as well as DMF (1.5 mL) were then
successively added. Subsequently, the reaction vial was capped and
then prestirred for 20 s. The mixture was irradiated (time, 30 min;
temperature, 60 °C; absorption level, high; ﬁxed hold time) until TLC
(petroleum ether/ethyl acetate V/V = 4/1) revealed that conversion of
the starting material 2a was complete. After the reaction mixture was
cooled to room temperature, water (20 mL) was added into the
reaction system, resulting in a black viscous liquid isolated from the
solution through liquid separation and extraction by using ethyl
acetate. The organic phase was concentrated by vacuum distillation
and was puriﬁed by ﬂash column chromatography (silica gel, mixtures
of petroleum ether/ethyl acetate) to aﬀord the desired pure product
5a as a yellow solid.

4-(4-Chlorophenyl)-6-hydroxy-5,7-diphenyl-5,6-dihydro-1H-
pyrrolo[3,2-b]pyridin-2(4H)-one (5a). Yellow solid (339 mg, 82%
yield): mp 242−244 °C.
1H NMR (400 MHz, DMSO-d6) δ 9.38 (s, 1H), 7.46−7.40 (m,
4H), 7.38−7.29 (m, 7H), 7.28−7.23 (m, 3H), 6.06 (d, J = 7.2 Hz,
1H), 5.15 (d, J = 1.2 Hz, 1H), 5.04 (s, 1H), 4.52 (dd, J1 = 2.0 Hz, J2 =
2.0 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 173.5, 150.3, 143.6,
139.1, 136.9, 132.7, 129.8, 129.3, 129.1, 129.0, 128.1, 128.0, 127.9,
126.6, 124.4, 112.1, 89.0, 72.7, 70.1; IR (KBr, ν) 3048, 2912, 2869,
1748, 1672, 838, 750, 612 cm−1; HRMS (APCI-TOF) m/z calcd for
[M + H]+ C25H20ClN2O2 415.1213, found 415.1217.

4-(4-Bromophenyl)-6-hydroxy-5,7-diphenyl-5,6-dihydro-1H-
pyrrolo[3,2-b]pyridin-2(4H)-one (5b). Yellow solid (362 mg, 79%
yield): mp 238−240 °C.
1H NMR (400 MHz, DMSO-d6) δ 9.38 (s, 1H), 7.60−7.54 (m,
2H), 7.44−7.38 (m, 2H), 7.36−7.25 (m, 7H), 7.25−7.16 (m, 3H),

6.06 (d, J = 7.2 Hz, 1H), 5.15 (d, J = 1.2 Hz, 1H), 5.04 (s, 1H), 4.52
(dd, J1 = 2.0 Hz, J2 = 2.0 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ
173.5, 150.2, 144.0, 139.1, 136.9, 132.7, 132.7, 129.3, 129.0, 128.1,
128.1, 127.9, 126.6, 124.7, 117.2, 112.2, 89.1, 72.7, 70.0; IR (KBr, ν)
3042, 2918, 2879, 1740, 1677, 826, 750, 613 cm−1; HRMS (APCI-
TOF) m/z calcd for [M + H]+ C25H20BrN2O2 459.0708,
found
459.0707.

7-(3-Chlorophenyl)-4,5-bis(4-chlorophenyl)-6-hydroxy-5,6-dihy-
dro-1H-pyrrolo[3,2-b]pyridin-2(4H)-one (5c). Yellow solid (280 mg,
58% yield): mp 221−223 °C.
1H NMR (400 MHz, DMSO-d6) δ 9.62 (s, 1H), 7.46−7.42 (m,
4H), 7.37−7.32 (m, 5H), 7.29−7.23 (m, 3H), 6.15 (d, J = 7.6 Hz,
1H), 5.16 (s, 1H), 5.04 (d, J = 12.8 Hz,1H), 4.48 (d, J = 7.2 Hz, 1H);
13C NMR (100 MHz, DMSO-d6) δ 173.6, 150.0, 143.3, 138.9, 137.9,
133.7, 133.7, 132.7, 130.8, 129.9, 129.4, 128.2, 128.1, 127.8, 126.8,
124.6, 110.4, 89.4, 79.4, 72.3, 69.3; IR (KBr, ν) 3554, 3061, 1638,
1492, 858, 764, 623 cm−1; HRMS (APCI-TOF) m/z calcd for [M +
H]+ C25H18Cl3N2O2 483.0434, found 483.0439.

5-(4-Bromophenyl)-4-(4-chlorophenyl)-6-hydroxy-7-(4-methoxy-
phenyl)-5,6-dihydro-1H-pyrrolo[3,2-b]pyridin-2(4H)-one (5d). Yel-
low solid (386 mg, 74% yield): mp 247−249 °C.

1H NMR (400 MHz, DMSO-d6) δ 9.34 (s, 1H), 7.55 (d, J = 8.0 Hz,
2H), 7.44 (d, J = 8.4 Hz, 2H), 7.37 (d, J = 8.4 Hz, 2H), 7.26 (d, J = 8.4
Hz, 4H), 6.91 (d, J = 8.4 Hz, 2H), 6.04 (d, J = 7.2 Hz, 1H), 5.13 (s,
1H), 5.01 (s, 1H), 4.47 (d, J = 6.8 Hz, 1H), 3.75 (s, 3H); 13C NMR
(100 MHz, DMSO-d6) δ 173.4, 159.1, 150.0, 143.5, 138.7, 132.2,
131.5, 129.9, 129. 6, 129.1, 129.0, 128.9, 124.4, 121.2, 114.5, 112.1,
89.1, 72.4, 69.4, 55.6; IR (KBr, ν) 3553, 3064, 1656, 1434, 874, 716,
623 cm−1; HRMS (APCI-TOF) m/z calcd for [M + H]+
C26H21BrClN2O3 523.0424, found 523.0415.

4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-6-hydroxy-7-phenyl-
5,6-dihydro-1H-pyrrolo[3,2-b]pyridin-2(4H)-one (5e). Yellow solid
(337 mg, 70% yield): mp 227−229 °C.
1H NMR (400 MHz, DMSO-d6) δ 9.50 (s, 1H), 7.69 (d, J = 2.0 Hz,
1H), 7.50−7.46 (m, 3H), 7.41 (d, J = 7.2 Hz, 2H), 7.36 (t, J = 7.6 Hz,
2H), 7.28−7.15 (m, 4H), 6.41 (d, J = 7.2 Hz, 1H), 5.23 (s, 1H), 5.12
(s, 1H), 4.43 (dd, J1 = 2.0 Hz, J2 = 2.0 Hz, 1H); 13C NMR (100 MHz,
DMSO-d6) δ 173.4, 150.2, 143.1, 136.8, 134.8, 133.9, 133.0, 132.6,
130.3, 130.1, 129.9, 129.2, 129.1, 128.6, 128.1, 124.8, 111.9, 89.5, 70.1,
67.4; IR (KBr, ν) 3552, 3070, 1638, 1492, 869, 749, 622 cm−1; HRMS
(APCI-TOF) m/z calcd for [M + H]+ C25H18Cl3N2O2 483.0434,
found 483.0429.

4-(4-Chlorophenyl)-5-(2,3-dichlorophenyl)-6-hydroxy-7-phenyl-
5,6-dihydro-1H-pyrrolo[3,2-b]pyridin-2(4H)-one (5f). Yellow solid
(313 mg, 65% yield): mp 202−204 °C.
1H NMR (400 MHz, DMSO-d6) δ 9.50 (s, 1H), 7.61 (d, J = 6.8 Hz,
1H), 7.47 (d, J = 8.8 Hz, 2H), 7.44−7.38 (m, 3H), 7.37−7.33 (m,
2H), 7.28−7.16 (m, 4H), 6.43 (d, J = 7.2 Hz, 1H), 5.30 (s, 1H), 5.14
(s, 1H), 4.45 (dd, J1 = 2.0 Hz, J2 = 2.0 Hz, 1H); 13C NMR (100 MHz,
DMSO-d6) δ 173.4, 150.2, 143.2, 138.4, 136.8, 133.1, 132.6, 130.7,
130.1, 123.0, 129.9, 129.3, 129.1, 128.1, 126.5, 124.7, 111.9, 89.5, 70.1,
68.3; IR (KBr, ν) 3554, 3058, 1684, 1492, 874, 778, 624 cm−1; HRMS
(APCI-TOF) m/z calcd for [M + H]+ C25H18Cl3N2O2 483.0434,
found 483.0435.

4-(4-Bromophenyl)-5-(2-chloro-5-methylphenyl)-6-hydroxy-7-
phenyl-5,6-dihydro-1H-pyrrolo[3,2-b]pyridin-2(4H)-one (5g). Yellow
solid (243 mg, 48% yield): mp 230−232 °C.
1H NMR (400 MHz, DMSO-d6) δ 9.45 (s, 1H), 7.71 (d, J = 8.8 Hz,
1H), 7.43−7.34 (m, 5H), 7.29−7.23 (m, 3H), 7.17 (d, J = 2.4 Hz,
1H), 7.13 (d, J = 8.4 Hz, 2H), 6.42 (d, J = 7.2 Hz, 1H), 5.20 (s, 1H),
5.01 (s, 1H), 4.42 (d, J = 7.2 Hz, 1H), 2.29 (s, 3H); 13C NMR (100
MHz, DMSO-d6) δ 173.6, 150.7, 141.6, 139.8, 136.8, 135.9, 135.7,
133.3, 132.7, 130.7, 130.3, 129.1, 128.1, 127.5, 123.1, 121.0, 111.6,
88.3, 70.2, 69.8, 20.9; IR (KBr, ν) 3516, 3027, 1639, 1025, 827, 766,
630 cm−1; HRMS (APCI-TOF) m/z calcd for [M + H]+
C26H21BrClN2O2 507.0475, found 507.0475.

General Procedure for the Synthesis of 6. Example for the
Synthesis of 6a. 4-Phenylamino-1H-pyrrol-2(5H)-one (2c, 1.0 mmol,
174 mg) was introduced in a 10 mL Initiator reaction vial; 1,3-
diphenyl-2,3-epoxypropan-1-one (3a, 1.0 mmol, 224 mg) and t-BuOLi
</para>
2787

DOI: 10.1021/acs.joc.5b00067
J. Org. Chem. 2015, 80, 2781−2789

The Journal of Organic Chemistry
<para sub=“exp”>
6-Phenyl-4-(p-tolyl)-3,4-dihydropyrrolo[3,2-b]pyrrol-2(1H)-one

(1.0 mmol, 80 mg) as well as DMF (1.5 mL) were then successively
added. Subsequently, the reaction vial was capped and then prestirred
for 20 s. The mixture was irradiated (time, 25 min; temperature, 60
°C; absorption level, high; ﬁxed hold time) until TLC (petroleum
ether/ethyl acetate V/V = 2/1) revealed that conversion of the starting
material 2c was complete. After the reaction mixture was cooled to
room temperature, water (20 mL) was added into the reaction system,
resulting in a black viscous liquid isolated from the solution through
liquid separation and extraction by using ethyl acetate. The organic
phase was concentrated by vacuum distillation and was puriﬁed by
ﬂash column chromatography (silica gel, mixtures of petroleum ether/
ethyl acetate) to aﬀord the desired pure product 6a as a white solid.
4,6-Diphenyl-3,4-dihydropyrrolo[3,2-b]pyrrol-2(1H)-one (6a).
White solid (192 mg, 70% yield): mp 206−208 °C.
1H NMR (400 MHz, DMSO-d6) δ 10.26 (s, 1H), 7.68 (d, J = 7.6
Hz, 2H), 7.46−7.30 (m, 7H), 7.10 (t, J = 6.8 Hz, 1H), 5.23 (d, J = 28.8
Hz, 3H); 13C NMR (100 MHz, DMSO-d6) δ 178.2, 157.6, 140.9,
134.0, 132.0, 130.0, 129.3, 128.0, 127.2, 122.7, 116.5, 112.3, 83.9, 60.5;
IR (KBr, ν) 3041, 2034, 1698, 1441, 1149, 826, 750 cm−1; HRMS
(APCI-TOF) m/z calcd for [M + H]+ C18H15N2O 275.1184, found
275.1187.
(6b). White solid (219 mg, 76% yield): mp 212−214 °C.
1H NMR (400 MHz, DMSO-d6) δ 10.21 (s, 1H), 7.66 (d, J = 7.6
Hz, 2H), 7.43 (t, J = 7.6 Hz, 2H), 7.33−7.24 (m, 5H), 5.17 (d, J = 14.4
Hz, 3H), 2.31 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 178.2,
157.7, 138.6, 134.0, 132.1, 131.8, 130.4, 129.2, 127.9, 127.2, 116.5,
112.0, 83.2, 60.6, 20.7; IR (KBr, ν) 3034, 2028, 1695, 1441, 1147, 828,
766 cm−1; HRMS (APCI-TOF) m/z calcd for [M + H]+ C19H17N2O
289.1341, found 289.1338.
6-(4-Methoxyphenyl)-4-phenyl-3,4-dihydropyrrolo[3,2-b]pyrrol-
2(1H)-one (6c). White solid (207 mg, 68% yield): mp 208−210 °C.
1H NMR (400 MHz, DMSO-d6) δ 10.19 (s, 1H), 7.65 (d, J = 8.0
Hz, 2H), 7.43 (t, J = 7.6 Hz, 2H), 7.35−7.30 (m, 3H), 7.02 (d, J = 8.8
Hz, 2H), 5.14 (d, J = 10.4 Hz, 3H), 3.77 (s, 3H); 13C NMR (100
MHz, DMSO-d6) δ 178.3, 157.9, 132.2, 129.2, 129.1, 127.1, 125.6,
121.1, 119.6, 118.0, 115.3, 115.0, 111.9, 60.8, 55.8; IR (KBr, ν) 3158,
2126, 1659, 1452, 1293, 826, 764 cm−1; HRMS (APCI-TOF) m/z
calcd for [M + H]+ C19H17N2O2 305.1290, found 305.1289.
6-(4-Chlorophenyl)-4-(p-tolyl)-3,4-dihydropyrrolo[3,2-b]pyrrol-
2(1H)-one (6d). White solid (199 mg, 62% yield): mp 201−203 °C.
1H NMR (400 MHz, DMSO-d6) δ 10.23 (s, 1H), 8.28 (s, 1H), 7.72
(d, J = 8.8 Hz, 2H), 7.44 (d, J = 8.8 Hz, 2H), 7.30−7.20 (m, 5H), 5.12
(s, 1H), 2.30 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 178.1, 155.5,
137.0, 134.9, 132.0, 131.8, 130.8, 130.1, 129.4, 128.9, 117.9, 113.1,
91.3, 83.6, 20.8; IR (KBr, ν) 3059, 2061, 1683, 1437, 1148, 819, 760
cm−1; HRMS (APCI-TOF) m/z calcd for [M + H]+ C19H16ClN2O
323.0951, found 323.0948.
6-(4-Methoxyphenyl)-4-(p-tolyl)-3,4-dihydropyrrolo[3,2-b]pyrrol-
2(1H)-one (6e). White solid (229 mg, 72% yield): mp 211−213 °C.
1H NMR (400 MHz, DMSO-d6) δ 10.10 (d, J = 17.6 Hz, 1H), 7.67
(d, J = 8.8 Hz, 1H), 7.61 (d, J = 8.8 Hz, 1H), 7.29−7.21 (m, 4H), 6.99
(d, J = 8.8 Hz, 2H), 5.13 (d, J = 18.8 Hz, 3H), 3.81 (d, J = 1.6 Hz,
3H), 2.30 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 178.1, 159.2,
159.0, 157.7, 138.7, 130.4, 124.7, 117.8, 116.4, 114.8, 114.6, 112.4,
83.2, 60.6, 55.7, 20.7; IR (KBr, ν) 3049, 2035, 1694, 1430, 1153, 827,
764 cm−1; HRMS (APCI-TOF) m/z calcd for [M + H]+ C20H19N2O2
319.1447, found 319.1445.
</para>
■ ASSOCIATED CONTENT
*S Supporting Information
1H and 13C NMR spectra for all pure products, and X-ray
crystal data (CIF) for 4j and 6b. This material is available free
of charge via the Internet at http://pubs.acs.org.

■ AUTHOR INFORMATION
Corresponding Authors
*Fax: 86-516-83500065. E-mail: wjhao@jsnu.edu.cn (W.-J.H.).
*Fax: 86-516-83500065. E-mail: jiangchem@jsnu.edu.cn (B.J.).

Article
*Fax: 86-516-83500065. E-mail: laotu@jsnu.edu.cn (S.-J.J.).
Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

We are grateful for ﬁnancial support from the NSFC (Nos.
21332005, 21232004, 21272095, and 21472071), PAPD of
Jiangsu Higher Education Institutions, the Qing Lan Project
(12QLG006), the Outstanding Youth Fund of JSNU, Robert A.
Welch Foundation (D-1361, USA), and NIH (R33DA031860,
USA), and Graduate Education Innovation Project of Jiangsu
Province (No. CXZZ14_0985).

■ REFERENCES

(1) For selected reviews, see: (a) Liddell, J. R. Nat. Prod. Rep. 2001,
18, 448. (b) Liddell, J. R. Nat. Prod. Rep. 2002, 19, 773. (c) Michael, J.
P. Nat. Prod. Rep. 2001, 18, 543. (d) Michael, J. P. Nat. Prod. Rep.
2002, 19, 719. (e) O’Hagan, D. Nat. Prod. Rep. 2000, 17, 435.
(f) Humphrey, A. J.; O’Hagan, D. Nat. Prod. Rep. 2001, 18, 494.
(g) Carreira, E. M.; Fessard, T. C. Chem. Rev. 2014, 114, 8257.
(h) Eftekhari-Sis, B.; Zirak, M.; Akbari, A. Chem. Rev. 2013, 113, 2958.
(2) Burgdorf, L.; Schultz, M.; Hofmann, T.; Hodous, B.; Potnick, J.;
Sutton, A. E.; Huck, B. R. PCT Int. Appl. WO 2012025187 A2
20120301, 2012.
(3) (a) Cadieux, J.-J.; Chafeev, M.; Chowdhury, S.; Douglas, A. F.;
Fu, J.; Langille, J.; Sun, S.; Wood, M. PCT Int. Appl. WO 2010078307
A1 20100708, 2010.
(4) (a) Kawaguchi, T.; Akatsuka, H.; Iijima, T.; Watanabe, T.;
Murakami, J.; Mitsui, T. Jpn. Kokai Tokkyo Koho JP 2006045220 A
20060216, 2006. (b) Kawaguchi, T.; Akatsuka, H.;
Iijima, T.;
Watanabe, T.; Murakami,
J.; Mitsui, T. PCT Int. Appl. WO
2004063202 A1 20040729, 2004.
(5) (a) Phillips, E. PCT Int. Appl. WO 2005042538 A1 20050512,
2005. (b) Lochead, A.; Jegham, S.; Galli, F.; Gallet, T. PCT Int. Appl.
WO 9842713 A1 19981001, 1998.
(6) Gordon, E. M.; Barrish, J. C.; Bisacchi, G. S.; Sun, C.-q.; Tino, J.
A.; Vite, G. D.; Zahler, R. U.S. Patent US 5,559,256 A 19960924, 1996.
(7) Kan-Fan, C.; Sevenet, T.; Hadi, H. A.; Bonin, M.; Quirion, J.-C.;
Husson, H.-P. Nat. Prod. Lett. 1995, 7 (4), 283.
(8) (a) Chen, W. Y.; Liebeskind, L. S. J. Am. Chem. Soc. 2009, 131
(35), 12546. (b) McLaughlin, N. P.; Evans, P.; Pines, M. Bioorg. Med.
Chem. 2014, 22 (7), 1993;(c) Tetrahedron 2001, 57, 1213.
(9) (a) Wee, G. H.; Fan, G.-J.; Bayirinoba, H. M. J. Org. Chem. 2009,
74 (21), 8261. (b) Fan, G.-j.; Wang, Z. Y.; Wee, G. H. Chem. Commun.
2006, 3732. (c) Taber, D. F.; DeMatteo, P. W. J. Org. Chem. 2012, 77
(9), 4235. (d) Heretsch, P.; Rabe, S.; Giannis, A. Org. Lett. 2009, 11
(23), 5410.
(10) Le Strat, F.; Maddaluno. J. Org. Lett. 2002, 4, 2791.
(11) Campos, P. J.; Anon, E.; Malo, M. C.; Rodriguez, M. A.
Tetrahedron 1999, 55, 14079.
(12) Kitamura, T.; Tsuda, K.; Fujiwara, Y. Tetrahedron Lett. 1998, 39,
5375.
(13) (a) Mathes, B. M.; Filla, S. A. Tetrahedron Lett. 2003, 44, 725.
(b) Arcadi, A.; Marinelli, F.; Cacchi, S. Synthesis 1986, 9, 749. (c) Yue,
D.; Yao, T.; Larock, R. C. J. Org. Chem. 2005, 70, 10292. (d) Arcadi,
A.; Cacchi, S.; Di Guiseppe, S.; Fabrizi, G.; Marinelli, F. Org. Lett.
2002, 4, 2409.
(14) (a) Chartoire, A.; Comoy, C.; Fort, Y. Tetrahedron 2008, 64,
10867. (b) Jasselin-Hinschberger, A.; Comoy, C.; Chartoire, A.; Fort,
Y. J. Org. Chem. 2013, 78, 5618. (c) Chartoire, A.; Comoy, C.; Fort, Y.
Org. Biomol. Chem. 2011, 9, 1839.
(15) Campos, P. J.; Arranz, J.; Rodriguez, M. A. Tetrahedron Lett.
1997, 38, 8397. (b) Shi, F.; Ma, N.; Zhou, D.-X.; Zhang, G.; Jiang, B.;
Tu, S.-J. Chin. J. Chem. 2009, 27, 1605. (c) Amari, M.; Fodili, M.; Kolli,
B. N.; Hoffmann, A. P.; Perie, J. J. Heterocycl. Chem. 2002, 39, 811.
(d) Jiang, B.; Wang, X.; Li, M.-Y.; Wu, Q.; Ye, Q.; Xu, H.-W.; Tu, S.-J.
Org. Biomol. Chem. 2012, 10, 8533. (e) Xue, L. Y.; Jiang, B.; Tu, M.-S.;

2788

DOI: 10.1021/acs.joc.5b00067
J. Org. Chem. 2015, 80, 2781−2789

The Journal of Organic Chemistry

Tu, S.-J. Tetrahedron Lett. 2012, 53, 6611. (f) Naeimi, H.; Rashid, Z.;
Zarnanib, A. H.; Ghahremanzadeh, R. New J. Chem. 2014, 38, 348.
(16) (a) Chernyshevaa, N. B.; Tsyganova, D. V.; Philchenkov, A. A.;
Zavelevichb, M. P.; Kiselyovc, A. S.; Semenova, R. V.; Semenova, M.
N.; Semenova, V. V. Bioorg. Med. Chem. Lett. 2012, 22, 2590. (b) Torii,
S.; Long, H.-X. Tetrahedron Lett. 1990, 31 (49), 7175. (c) Jiang, B.;
Feng, B.-M.; Wang, S.-L.; Tu, S.-J.; Li, G. Chem.Eur. J. 2012, 18,
9823. (d) Li, Y.; Yu, Y.; Tu, M.-S.; Jiang, B.; Wang, S.-L.; Tu, S.-J. Org.
Biomol. Chem. 2012, 10, 5361. (e) Kaoua, R.; Bellara, N. K.; Roisnel,
T.; Yann, L. G.; Lorcy, D. Tetrahedron 2013, 69, 4636.
(17) For the preparation of 1,3-diaryl-2,3-epoxypropan-1-one, refer
to: (a) Shi, D.-Q.; Zhang, S.; Zhuang, Q.-Y.; Wang, X.-S.; Tu, S.-J.; Hu,
H.-W. Chin. J. Chem. 2003, 21, 680. (b) Tanaka, K.; Shiraishi, R. Green
Chem. 2001, 3, 135.

Article

2789

DOI: 10.1021/acs.joc.5b00067
J. Org. Chem. 2015, 80, 2781−2789

